REFERENCES
- Rennard S, Decramer M, Calverley P M, Pride N B, Soriano J B, Vermeire P A, Vestbo J. Impact of COPD in North America and Europe in 2000: Subjects' perspective of confronting COPD international survey. Eur Respir J 2002; 20: 799–805
- Barr R G, Celli B R, Martinez F J, Ries A L, Rennard S I, Reilly J J, Jr., Sciurba F C, Thomashow B M, Wise R A. Physician and patient perceptions in COPD: The COPD resource network needs assessment survey. Am J Med 2005; 118: 1415
- Pickett J P. The American Heritage Dictionary of the English language: 4th edition. Houghton Mifflin Company, Boston 2006
- MicrosoftWord. Dictionary 11.0 ed. Microsoft Corporation, Redmond, WA 2004
- Cruse M A. The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: A patient perspective. J COPD 2007, (In press)
- Casaburi R. Factors determining constant work rate exercise tolerance in copd and their role in dictating the minimal clinically important difference in response to interventions. J COPD 2005; 2: 131–136
- Brown C D, Wise R A. Field tests of exercise in COPD: The six-minute walk test and the shuttle walk test. J COPD 2007, (In press)
- Reardon J Z. COPD and exercise: What's really important? A nursing perspective. J COPD 2007, (In press)
- Larson J L. Functional performance and physical activity in chronic obstructive pulmonary disease: Theoretical perspectives. J COPD 2007, (In press)
- Leidy N K. Subjective measurement of activity in chronic obstructive pulmonary disease. J COPD 2007, (In press)
- Hill K, Goldstein R S. Limited functional performance in chronic obstructive pulmonary disease: nature, causes and measurement. J COPD 2007, (In press)
- Wallack Zu R. How you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. J COPD 2007, (In press)
- Belfer M H. The impact of exercise on activities of daily living and quality of life: A primary care physician's perspective. J COPD 2007, (In press)
- Jones P W. Activity limitation and quality of life in COPD. J COPD 2007, (In press)
- Casaburi R. Activity monitoring in assessing activities of daily living. J COPD 2007, (In Press)
- Pepin V, Saey D, Laviolette L, Maltais F. Exercise capacity in chronic obstructive pulmonary disease: Mechanisms of limitation. J COPD 2007, (In press)
- O'Donnell D E, Laveneziana P. Dyspnea and activity limitation in COPD: Mechanical factors. J COPD 2007, (In press)
- Berry M J. The relationship between exercise tolerance and other outcomes in COPD. J COPD 2007, (In press)
- Kaplan R M, Ries A L. Quality of life: Concept and definition. J COPD 2007, (In press)
- O'Donnell D E, Voduc N, Fitzpatrick M, Webb K A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86–94
- O'Donnell D E, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832–840
- Somfay A, Porszasz J, Lee S M, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001; 18: 77–84
- Naunheim K S, Wood D E, Mohsenifar Z, Sternberg A L, Criner G J, De Camp M M, Deschamps C C, Martinez F J, Sciurba F C, Tonascia J. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006; 82: 431–443
- O'Donnell D E, Sciurba F, Celli B, Mahler D A, Webb K A, Kalberg C J, Knobil K. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130: 647–656
- Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390–1413
- Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 19–38